Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
VANGUARD CAPITAL MANAGEMENT LLC TAP Molson Coors Beverage Co 13G/A 4.61% 15d
First Trust Portfolios L.P. AFK VanEck ETF Trust 13G/A 4.37% 15d
VANGUARD PORTFOLIO MANAGEMENT LLC FSLY Fastly, Inc. 13G/A 6.22% 15d
VANGUARD CAPITAL MANAGEMENT LLC TBBK Bancorp, Inc. 13G/A 4.97% 15d
VANGUARD CAPITAL MANAGEMENT LLC HCSG Healthcare Services Group Inc 13G/A 4.83% 15d
VANGUARD PORTFOLIO MANAGEMENT LLC AMBA Ambarella Inc 13G/A 7.04% 15d
VANGUARD CAPITAL MANAGEMENT LLC ASH Ashland Inc. 13G/A 4.92% 15d
Wu Capital Limited NAMI Jinxin Technology Holding Co 13G/A 0% 15d
VANGUARD CAPITAL MANAGEMENT LLC HLF Herbalife Ltd. 13G/A 4.96% 15d
VANGUARD CAPITAL MANAGEMENT LLC ARHS Arhaus, Inc. 13G/A 4.95% 15d
VANGUARD PORTFOLIO MANAGEMENT LLC SLB Slb Limited 13G/A 4.97% 15d
VANGUARD CAPITAL MANAGEMENT LLC CAC Camden National Corp 13G/A 4.96% 15d
VANGUARD CAPITAL MANAGEMENT LLC HWKN Hawkins Inc 13G 5.04% 15d
Poleg Tamir REAX Real REMAX Group Inc. 13G/A 0% 15d
Guy Gamzu REAX Real REMAX Group Inc. 13G/A 0% 15d
Freebird Partners LP ERNA Ernexa Therapeutics Inc. 13G/A 7% 15d
Moalem Moshe NNOX Nano-X Imaging Ltd. 13D 8.49% 16d
Corley Thomas John SOBR SOBR Safe, Inc. 13G/A 19.5% 16d
Mark B. Lucky VISM Visium Technologies, Inc. 13D/A 9.43% 16d
Family Trading Inc. TOPS Top Ships Inc. 13D/A 21.95% 16d
Deutsche Telekom AG TMUS T-Mobile US, Inc. 13D/A 55.9% 16d
Liu Ming Hui ESYN EnerSyn Global Inc. 13D/A 94.8% 16d
WHITMORE BRADFORD T ULBI Ultralife Corp 13D/A 40.3% 16d
Carson, LLC GAIA Gaia, Inc 13G 5.1% 16d
Bastion Trading Limited SKYA SkyAI, Inc. 13D/A 4.3% 16d
D. E. Shaw & Co., L.P. GOSS Gossamer Bio, Inc. 13D/A 4.2% 16d
Mark B. Lucky VISM Visium Technologies, Inc. 13D/A 9.43% 16d
FOXO TECHNOLOGIES INC. LUDG Ludwig Enterprises, Inc. 13D 74.9% 16d
Kosow Keith AMOD Alpha Modus Holdings, Inc. 13G 9.88% 16d
FOUAD AHMED RBNE Robin Energy Ltd. 13G 43% 16d
Bain Capital Life Sciences Opportunities IV, L.P. ADCT ADC Therapeutics SA 13G 9.99% 16d
Murchinson Ltd. NNDM Nano Dimension Ltd. 13D/A 10.1% 16d
Trails Edge Capital Partners, LP AVTX Avalo Therapeutics, Inc. 13G 5.2% 16d
Bubble Holdings, LLC ZVIA Zevia PBC 13D 16.1% 16d
Sky Frontier Foundation SDEV Stablecoin Development Corp 13D/A 9.9% 16d
WELLS FARGO & COMPANY/MN ECF Ellsworth Growth & Income Fund Ltd 13G/A 1.9% 16d
Sumitomo Mitsui Trust Group, Inc. ARCT Arcturus Therapeutics Holdings Inc. 13G/A 5.9% 16d
Dr. Beth C. Seidenberg ("Seidenberg") LTGO Latigo Biotherapeutics, Inc. 13G 19.9% 16d
WELLS FARGO & COMPANY/MN ARDC Ares Dynamic Credit Allocation Fund, Inc. 13G/A 7.8% 16d
PRINCIPAL GLOBAL INVESTORS, LLC COLL Collegium Pharmaceutical, Inc 13G/A 4.7% 16d
Millennium Management LLC FBIO Fortress Biotech, Inc. 13G/A 6.5% 16d
Sumitomo Mitsui Trust Group, Inc. MFG Mizuho Financial Group Inc 13G/A 5% 16d
WELLS FARGO & COMPANY/MN OPP RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. 13G/A 7.6% 16d
Decheng Capital Management III (Cayman), LLC BYSI BeyondSpring Inc. 13G/A 7.5% 16d
PRINCIPAL GLOBAL INVESTORS, LLC H Hyatt Hotels Corp 13G/A 7.5% 16d
PRINCIPAL GLOBAL INVESTORS, LLC CSTL Castle Biosciences Inc 13G/A 4.9% 16d
WELLS FARGO & COMPANY/MN COSM Cosmos Health Inc. 13G 5.1% 16d
PRINCIPAL GLOBAL INVESTORS, LLC NICE NICE Ltd. 13G/A 5.6% 16d
KW Capital Partners Ltd. NUR Nuran Wireless Inc. 13G/A 8.9% 16d
MILLENNIUM MANAGEMENT LLC AAC Ares Acquisition Corp III 13G/A 3.9% 16d